$34.84
0.07[0.20%]
At close: Apr 19
$34.84
0[0.00%]
After Hours: 4:00PM EDT
Collegium Pharmaceutical
(NASDAQ:COLL)Collegium Pharmaceutical Stock (NASDAQ:COLL), Analyst Ratings, Price Targets, Predictions
Collegium Pharmaceutical Inc has a consensus price target of $30.71, established from looking at the 28 latest analyst ratings. The last 3 analyst ratings were released from Needham, Truist Securities, and Piper Sandler on April 11, 2024, February 26, 2024, and February 23, 2024. With an average price target of $39.67 between Needham, Truist Securities, and Piper Sandler, there's an implied 13.85% upside for Collegium Pharmaceutical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Needham
Truist Securities
Piper Sandler
Truist Securities
Jefferies
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Collegium Pharmaceutical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/11/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 14.81% | Needham | Serge Belanger | → $40 | Reiterates | Buy → Buy | Get Alert |
| 02/26/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 14.81% | Truist Securities | Les Sulewski | $37 → $40 | Maintains | Buy | Get Alert |
| 02/23/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 11.94% | Piper Sandler | David Amsellem | $37 → $39 | Reiterates | Overweight → Overweight | Get Alert |
| 02/02/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 14.81% | Needham | Serge Belanger | → $40 | Reiterates | Buy → Buy | Get Alert |
| 01/04/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 14.81% | Needham | Serge Belanger | $36 → $40 | Maintains | Buy | Get Alert |
| 01/04/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 6.2% | Truist Securities | Gregg Gilbert | $31 → $37 | Maintains | Buy | Get Alert |
| 01/04/2024 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 6.2% | Jefferies | Glen Santangelo | $30 → $37 | Downgrade | Buy → Hold | Get Alert |
| 08/25/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 3.33% | Needham | Serge Belanger | $35 → $36 | Maintains | Buy | Get Alert |
| 08/04/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | — | HC Wainwright & Co. | Oren Livnat | — | Reiterates | → Neutral | Get Alert |
| 08/04/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | → $35 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | → $35 | Reiterates | Buy → Buy | Get Alert |
| 05/05/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | → $35 | Reiterates | → Buy | Get Alert |
| 05/02/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | -13.89% | Jefferies | Glen Santangelo | → $30 | Assumes | → Buy | Get Alert |
| 04/19/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | → $35 | Reiterates | → Buy | Get Alert |
| 02/24/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | → $35 | Reiterates | → Buy | Get Alert |
| 02/08/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | → $35 | Reiterates | → Buy | Get Alert |
| 01/05/2023 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | 0.46% | Needham | Serge Belanger | $34 → $35 | Maintains | Buy | Get Alert |
| 11/04/2022 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | -2.41% | Needham | Serge Belanger | $36 → $34 | Maintains | Buy | Get Alert |
| 08/08/2022 | COLL | Buy Now | Collegium Pharmaceutical | $34.84 | — | HC Wainwright & Co. | Oren Livnat | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Collegium Pharmaceutical (COLL)?
The latest price target for Collegium Pharmaceutical (NASDAQ: COLL) was reported by Needham on April 11, 2024. The analyst firm set a price target for $40.00 expecting COLL to rise to within 12 months (a possible 14.81% upside). 13 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Collegium Pharmaceutical (COLL)?
The latest analyst rating for Collegium Pharmaceutical (NASDAQ: COLL) was provided by Needham, and Collegium Pharmaceutical reiterated their buy rating.
When was the last upgrade for Collegium Pharmaceutical (COLL)?
There is no last upgrade for Collegium Pharmaceutical.
When was the last downgrade for Collegium Pharmaceutical (COLL)?
The last downgrade for Collegium Pharmaceutical Inc happened on January 4, 2024 when Jefferies changed their price target from $30 to $37 for Collegium Pharmaceutical Inc.
When is the next analyst rating going to be posted or updated for Collegium Pharmaceutical (COLL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Collegium Pharmaceutical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Collegium Pharmaceutical was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
Is the Analyst Rating Collegium Pharmaceutical (COLL) correct?
While ratings are subjective and will change, the latest Collegium Pharmaceutical (COLL) rating was a reiterated with a price target of $0.00 to $40.00. The current price Collegium Pharmaceutical (COLL) is trading at is $34.84, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.